QUICK SCAN
10 THE WEEK · JULY 29, 2018
HEALTH
EXERCISE HELPS CHILDHOOD
CANCER SURVIVORS TO LIVE LONGER
Exercise may help adult survivors of childhood cancer live longer. Adult survivors of
childhood cancers are known to have an increased risk of death from cancer recurrence,
early heart disease or new cancers and have a life expectancy that is generally 10 years less
than the general population.
The study published in JAMA Oncology sought to examine whether exercise reduces this risk.
The study included 15,450 adult cancer survivors who had been diagnosed with cancer
before age 21 years. Half of them were at least 26 years old at the start of the study.
During an average follow up of 9.6 years, 1,063 of them died.
The participants’ exercise levels and intensity were scored based on a measure known as
metabolic equivalent of task (MET) hours per week. About 70 per cent of the participants did
not exercise.
At 15 years, all-cause mortality was almost 11.7 per cent for those who did not exercise at
all. The rate was 8.6 per cent for those who achieved three to six MET hours per week; 7.4
per cent for 9 to 12 MET hours a week; and 8 per cent for 15 to 21 MET hours per week.
Among a subset of 5,689 survivors, those who increased their exercise significantly over an
eight-year period had a 40 per cent lower risk for all-cause mortality during the study period.
“Vigorous exercise in early adulthood and increased exercise over eight years was associated
with lower risk of mortality in adult survivors of childhood cancer,” the study concluded.
A new drug to treat excessive bleeding after
childbirth could save the lives of thousands of
women, especially in low- and lower-middle-
income countries, according to a study led by
the World Health Organisation.
Postpartum haemorrhage is the most
common cause of maternal death. Nearly
70,000 women die each year from PPH, which
also increases the risk of their babies dying
within one month.
Currently the drug of choice to prevent PPH
is oxytocin. But oxytocin has to be stored and
transported at 2–8 degrees Celsius, which is
not practical in many countries due to poor
refrigeration facilities and unreliable power
supplies.
The new drug, heat-stable carbetocin, is as
NEW DRUG COULD SAVE MANY
MOMS DURING CHILDBIRTH